What is the recommended antibiotic regimen for periorbital cellulitis?

Antibiotic Treatment for Periorbital Cellulitis

For uncomplicated periorbital cellulitis in outpatients, treat with oral antibiotics targeting β-hemolytic streptococci and Staphylococcus aureus for 5-6 days; for hospitalized patients or those with systemic signs, use IV ceftriaxone with or without clindamycin/metronidazole for 7-10 days.

Outpatient Management (Mild Cases)

For patients who can be managed as outpatients—those without systemic toxicity, vision changes, or orbital involvement—oral antibiotic therapy is appropriate:

First-Line Oral Options:

• Cephalexin 500 mg PO QID (pediatric: 25 mg/kg/day in 4 divided doses) 1
• Dicloxacillin 500 mg PO QID (pediatric: 25 mg/kg/day in 4 divided doses) 1
• Amoxicillin-clavulanate 875/125 mg PO BID (pediatric: 25 mg/kg/day in 2 divided doses) 1

These β-lactams provide coverage for both streptococci and methicillin-susceptible S. aureus (MSSA), which are the predominant pathogens in periorbital cellulitis 2, 3.

Duration:

5-6 days is sufficient for uncomplicated cases with close follow-up 4. This shorter duration reduces antibiotic exposure while maintaining efficacy, as demonstrated in cellulitis trials showing non-inferiority of 5-6 day courses compared to 10-day regimens 5.

When to Add MRSA Coverage:

If there is purulent drainage, treatment failure on β-lactams, or high local MRSA prevalence, add:

• Clindamycin 300-450 mg PO TID (pediatric: 10-13 mg/kg/dose every 6-8h, max 40 mg/kg/day) 6
• TMP-SMX 1-2 DS tablets PO BID plus a β-lactam (pediatric: TMP 4-6 mg/kg/dose every 12h) 6

Critical caveat: TMP-SMX and tetracyclines lack reliable streptococcal coverage and should not be used as monotherapy 6. Tetracyclines are contraindicated in children <8 years 7, 6.

Inpatient Management (Moderate to Severe Cases)

Hospitalization is indicated for:

• Systemic toxicity (fever, ill appearance)
• Vision changes or orbital involvement
• Age extremes (very young children)
• Failure of outpatient therapy
• Inability to take oral medications 6, 7

IV Antibiotic Regimens:

Most effective combination based on recent evidence:

• Ceftriaxone 1-2 g IV daily (pediatric: 50-75 mg/kg/day) PLUS metronidazole 500 mg IV every 6-8h (pediatric: 7.5 mg/kg/dose every 6h) 8

This combination showed the shortest hospital stay (3.8 days) and lowest surgical intervention rate compared to ceftriaxone alone (5.8 days) or co-amoxiclav (4.5 days) in a UK multicenter study 8.

Alternative regimens:

• Ceftriaxone alone 1-2 g IV daily (pediatric: 50-75 mg/kg/day) 2
• Ceftriaxone + clindamycin 600 mg IV every 8h (pediatric: 10-13 mg/kg/dose every 6-8h) 2
• Ampicillin-sulbactam 1.5-3 g IV every 6-8h 3

For MRSA coverage in severe cases or treatment failure:

• Vancomycin 15-20 mg/kg/dose IV every 8-12h (pediatric: 15 mg/kg/dose every 6h) 6
• Linezolid 600 mg PO/IV BID (pediatric: 10 mg/kg/dose every 8h) 6

Duration:

7-10 days total (IV followed by oral step-down when clinically stable) 6, 7, 2. Clinical stability includes resolution of fever, ability to take oral medications, and improvement in periorbital swelling.

Key Pathogens and Microbiology

The most common organisms are:

• Staphylococcus aureus (including MRSA in some regions) 2, 3, 9
• Streptococcus pneumoniae 2
• β-hemolytic streptococci (Groups A, B, C, G) 1
• Streptococcus constellatus (aggressive abscess former) 10

Important note: Blood and wound cultures are frequently negative 2, but should still be obtained in hospitalized patients or those with severe infection 6, 7.

Adjunctive Measures

Intranasal decongestants and corticosteroids may reduce progression to surgical intervention when sinusitis is the underlying cause 8. This is particularly relevant since sinusitis is the most common predisposing factor in 43-79% of cases 2, 3.

Common Pitfalls to Avoid

1. Do not use TMP-SMX or tetracyclines as monotherapy—they lack adequate streptococcal coverage 6
2. Do not default to 10-day courses—5-6 days is sufficient for uncomplicated cases 4, 5
3. Do not delay ophthalmology consultation if there is any concern for orbital involvement (proptosis, ophthalmoplegia, vision changes)
4. Do not use rifampin as monotherapy or adjunctive therapy 6, 7
5. Watch for treatment failure requiring surgical drainage—occurs in 16-19% of cases 2

Transition to Oral Therapy

Switch from IV to oral antibiotics when:

• Afebrile for 24 hours
• Decreasing periorbital swelling and erythema
• Able to tolerate oral medications
• No vision changes

Complete the total 7-10 day course with oral agents matching the IV spectrum (e.g., cephalexin, amoxicillin-clavulanate, or clindamycin if MRSA coverage needed) 6, 7.